Author(s):
1. Somia Gul:
Faculty of Pharmacy, Jinnah University for Women Karachi, Pakistan
2. Fakhra Khalid:
Faculty of Pharmacy,Jinnah University for Women Karachi, Pakistan
3. Maheen Nafees Khan:
Faculty of Pharmacy,Jinnah University for Women Karachi, Pakistan
4. Muhammad Tanweer Alam:
Faculty of Pharmacy,Jinnah University for Women Karachi, Pakistan
Abstract:
An accurate and economical spectrophotometric method for the estimation of Moxifloxacin HC1 in tablet dosage form has been developed and validated. The comparative studies of its different brands were assessed through evaluation of official and non official standards such as disintegration and dissolution with the specification of US pharmacopeia. The proposed developed method was based on the UV absorbance, 0.1 M HC1 used as a solvent. In this method Moxifloxacin shows wavelength maxima at 294nm and method was validated as per ICH guidelines for linearity, precision and accuracy. This proposed method was successfully applied for the analysis of different brands of Moxifloxacin tablets available in the market and recovery study also revealed that there was no interaction occurred from the excipients present in the tablet.
Page(s):
41-49
DOI:
DOI not available
Published:
Journal: RADS Journal of Pharmacy & Pharmaceutical Sciences, Volume: 3, Issue: 2, Year: 2015
Keywords:
dissolution
,
Validation
,
spectrophotometry
,
disintegration
,
moxifloxacin
References:
References are not available for this document.
Citations
Citations are not available for this document.